0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma
Stopped early · Phase 2
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Drugs used in chemotherapy, such as pentamidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well pentamidine works in treating patients with relapsed or refractory melanoma.
Key facts
- Study ID
- NCT00729807
- Run by
- University of Maryland, Baltimore
- People needed
- 6
- Starts
- 2008-07-01
- Expected to finish
- 2012-11-01
- Last updated by the study team
- 2019-08-16
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Greenebaum Cancer Center at University of Maryland Medical Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.